225 related articles for article (PubMed ID: 29899871)
1. Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.
AbouAitah K; Swiderska-Sroda A; Farghali AA; Wojnarowicz J; Stefanek A; Gierlotka S; Opalinska A; Allayeh AK; Ciach T; Lojkowski W
Oncotarget; 2018 May; 9(41):26466-26490. PubMed ID: 29899871
[TBL] [Abstract][Full Text] [Related]
2. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
3. Co-Delivery System of Curcumin and Colchicine Using Functionalized Mesoporous Silica Nanoparticles Promotes Anticancer and Apoptosis Effects.
AbouAitah K; Soliman AAF; Swiderska-Sroda A; Nassrallah A; Smalc-Koziorowska J; Gierlotka S; Lojkowski W
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559264
[TBL] [Abstract][Full Text] [Related]
4. Virucidal Action Against Avian Influenza H5N1 Virus and Immunomodulatory Effects of Nanoformulations Consisting of Mesoporous Silica Nanoparticles Loaded with Natural Prodrugs.
AbouAitah K; Swiderska-Sroda A; Kandeil A; Salman AMM; Wojnarowicz J; Ali MA; Opalinska A; Gierlotka S; Ciach T; Lojkowski W
Int J Nanomedicine; 2020; 15():5181-5202. PubMed ID: 32801685
[TBL] [Abstract][Full Text] [Related]
5. Physical Characterization and Safety Evaluation of Folic Acid-conjugated Mesoporous Silica Nanoparticles Loaded with Rhodojaponin III.
Yang Q; Zhao C; Yang J; Zhao J; Feng Y; Liu M; Zhang J
Curr Drug Deliv; 2023; 20(10):1559-1568. PubMed ID: 36366851
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel.
Khosravian P; Shafiee Ardestani M; Khoobi M; Ostad SN; Dorkoosh FA; Akbari Javar H; Amanlou M
Onco Targets Ther; 2016; 9():7315-7330. PubMed ID: 27980423
[TBL] [Abstract][Full Text] [Related]
7. Carboxymethyl Cellulose-Grafted Mesoporous Silica Hybrid Nanogels for Enhanced Cellular Uptake and Release of Curcumin.
Tiwari N; Nawale L; Sarkar D; Badiger MV
Gels; 2017 Feb; 3(1):. PubMed ID: 30920505
[TBL] [Abstract][Full Text] [Related]
8. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
[TBL] [Abstract][Full Text] [Related]
9. Co-Delivery of Cisplatin and Curcumin Using Mesoporous Silica Nanoparticles to Improve their Anticancer Effects.
Dizaj SM; Bolouri Ebrahimi SS; Jafari S; Basiri A; Yazdani J; Sharifi S; Abdolahinia ED
Pharm Nanotechnol; 2023; 11(4):364-372. PubMed ID: 36974418
[TBL] [Abstract][Full Text] [Related]
10. Controlled synthesis and size effects of multifunctional mesoporous silica nanosystem for precise cancer therapy.
Ma B; He L; You Y; Mo J; Chen T
Drug Deliv; 2018 Nov; 25(1):293-306. PubMed ID: 29334793
[TBL] [Abstract][Full Text] [Related]
11.
Mohebian Z; Babazadeh M; Zarghami N
Adv Pharm Bull; 2023 Mar; 13(2):317-327. PubMed ID: 37342377
[No Abstract] [Full Text] [Related]
12. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution.
Saroj S; Rajput SJ
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1115-S1130. PubMed ID: 30669865
[TBL] [Abstract][Full Text] [Related]
13. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery.
Al-Nadaf AH; Dahabiyeh LA; Jawarneh S; Bardaweel S; Mahmoud NN
Pharm Dev Technol; 2021 Jun; 26(5):582-591. PubMed ID: 33729906
[TBL] [Abstract][Full Text] [Related]
15. siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells.
Heidari R; Khosravian P; Mirzaei SA; Elahian F
Sci Rep; 2021 Oct; 11(1):20531. PubMed ID: 34654836
[TBL] [Abstract][Full Text] [Related]
16. Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy.
AbouAitah K; Lojkowski W
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33499150
[TBL] [Abstract][Full Text] [Related]
17. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
[TBL] [Abstract][Full Text] [Related]
18. Effect of Curcumin-Loaded Mesoporous Silica Nanoparticles on the Head and Neck Cancer Cell Line, HN5.
Sharifi S; Dalir Abdolahinia E; Ghavimi MA; Dizaj SM; Aschner M; Saso L; Khan H
Curr Issues Mol Biol; 2022 Oct; 44(11):5247-5259. PubMed ID: 36354669
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles for drug and gene delivery.
Zhou Y; Quan G; Wu Q; Zhang X; Niu B; Wu B; Huang Y; Pan X; Wu C
Acta Pharm Sin B; 2018 Mar; 8(2):165-177. PubMed ID: 29719777
[TBL] [Abstract][Full Text] [Related]
20. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
Nasri N; Saharkhiz S; Dini G; Yousefnia S
Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
